Table 3 General and laboratory characteristics of the study population according to mortality or survival status
Variables | Mortality (n = 44) | Survival (n = 361) | P |
|---|---|---|---|
Age(years) | 67.57 ± 15.58 | 65.79 ± 13.22 | 0.410 |
Males (%) | 28 (63.6) | 246 (68.1) | 0.546 |
BMI(kg/m2) | 25.68 ± 4.8 | 27.05 ± 6.2 | 0.165 |
Heart rate (beats per minute) | 83.04 ± 16 | 85.56 ± 19.9 | 0.420 |
Ischemic heart disease (%) | 37 (84.1) | 321(88.9) | 0.345 |
Diabetes mellitus (%) | 21 (47.7) | 149 (41.3) | 0.413 |
Hypertension (%) | 16 (36.4) | 178 (49.3) | 0.105 |
Stroke (%) | 1 (2.3) | 17 (4.7) | 0.459 |
Kidney diseases (%) | 19 (43.2) | 160 (44.3) | 0.886 |
COPD (%) | 31 (70.5) | 111 (30.7) |  < 0.001 |
Smoking status (%) | 14 (31.8) | 138 (38.2) | 0.407 |
Systolic blood pressure (mmHg) | 116.7 ± 19.5 | 121.54 ± 25.6 | 0.228 |
Diastolic blood pressure (mmHg) | 72.29 ± 12.5 | 76.08 ± 15.9 | 0.130 |
Left ventricular ejection fraction (%) | Â | Â | Â |
 < 30 | 34 (77.3) | 265 (73.4) | 0.338 |
 30–40 | 3 (6.8) | 58 (16.1) |  |
 40–50 | 4 (9.1) | 23 (6.4) |  |
 > 50 | 3 (6.8) | 15 (4.2) |  |
Hemoglobin (g/dl) | 13.12 ± 2.3 | 13.65 ± 3.1 | 0.279 |
WBC (106/l) | 5.9 ± 3.2 | 5.3 ± 3.1 | 0.199 |
Neutrophils (%) | 73 ± 9.5 | 67.4 ± 12.5 | 0.005 |
Lymphocytes (%) | 17.9 ± 7.3 | 22.5 ± 9.6 | 0.002 |
Platelets (109/l) | 170.38 ± 61.8 | 192.89 ± 69.4 | 0.041 |
Platelet-to-lymphocyte ratio | 127.80 ± 77.5 | 129.03 ± 108.6 | 0.942 |
Sodium (mEq/l) | 134.7 ± 5.4 | 136.23 ± 4.7 | 0.049 |
Potassium (mEq/l) | 3.96 ± 0.4 | 3.98 ± 0.5 | 0.862 |
Blood urea nitrogen (mg/dl) | 103.73 ± 61.09 | 80.88 ± 50.63 | 0.006 |
Creatinine (mg/dl) | 1.66 ± 0.7 | 2.4 ± 1 | 0.643 |